Fluoxetine versus phenelzine in obsessive-compulsive disorder.
Golwyn
D H
DH
Sevlie
C P
CP
D000928:Antidepressive Agents / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic / Q000592:standards*; D004334:Drug Administration Schedule; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000523:psychology; D010624:Phenelzine / Q000627:therapeutic use*; D010919:Placebos; D012107:Research Design / Q000592:standards; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
D000928:Antidepressive Agents; D005473:Fluoxetine; D010624:Phenelzine; D010919:Placebos; D017367:Selective Serotonin Reuptake Inhibitors